HomeIndustriesHealthcareOverlooked Stock: PTGX
00:00
00:00
04:21
Overlooked Stock: PTGX

Overlooked Stock: PTGX

Protagonist Therapeutics (PTGX) rallied 45% after its latest drug trial to treat people with active ulcerative colitis saw success. George Tsilis says there's more positive catalysts behind the stock, particularly its cash pile.

Market On Close

10 Mar 2025

SHARE

ON AIR
1:00 pm
Fast Market
replay
education
5:00 am
Your First Trade
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
The Wrap
REPLAY
7:00 am
Fast Market
REPLAY
8:00 am
Next Gen Investing
REPLAY
9:00 am
Market Overtime
REPLAY
education
9:30 am
Inside the Mind of a Trader
REPLAY
education
10:00 am
Inside the Mind of a Trader
REPLAY
education
10:30 am
Inside the Mind of a Trader
REPLAY
11:00 am
Market Overtime
REPLAY
12:00 pm
The Wrap
REPLAY
ON AIR
1:00 pm
Fast Market
REPLAY
2:00 pm
Next Gen Investing
REPLAY
education
3:00 pm
Your First Trade
REPLAY
education
3:30 pm
Your First Trade
REPLAY
education
4:00 pm
Your First Trade
REPLAY
education
4:30 pm
Your First Trade
REPLAY
education
5:00 pm
Your First Trade
REPLAY
education
5:30 pm
Your First Trade
REPLAY
education
6:00 pm
Your First Trade
REPLAY
education
6:30 pm
Your First Trade
REPLAY
education
7:00 pm
Your First Trade
REPLAY
education
7:30 pm
Your First Trade
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market Overtime
REPLAY
9:00 pm
Fast Market
REPLAY
10:00 pm
Next Gen Investing
REPLAY
11:00 pm
The Wrap
REPLAY
12:00 am
Market Overtime
REPLAY
12:30 am
Market Overtime
REPLAY
1:00 am
The Wrap
REPLAY
2:00 am
Market Overtime
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY

Schwab Network's Newsletters

Daily insights for every investor